Skip to main content
Equibles

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC

Position in RYTM — Rhythm Pharmaceuticals, Inc.

CIK 861177 NEW YORK, NY
Back to RYTM Full portfolio

Position in RYTM

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$57,163,791
+$10,073,888 QoQ
Shares Held
514,850
-4.9% QoQ
Ownership
0.748%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
25 quarters on record
Voting authority Sole 47% Shared 0% None 53%

Common Shares in RYTM Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds $4,443,898,601 across 206 Biotechnology names. RYTM ranks #16 (1.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 3,086,683 $1,533,248,041
2 REGN
Regeneron Pharmaceuticals, Inc.
 716,560 $446,803,817
3 ALNY
Alnylam Pharmaceuticals, Inc.
 727,848 $219,104,078
4 INCY
Incyte Corp
 1,508,720 $171,028,494
5 RVMD
Revolution Medicines, Inc.
 912,335 $170,862,094
6 INSM
INSMED Inc
 1,335,071 $142,345,265
7 IONS
Ionis Pharmaceuticals Inc
 1,454,672 $115,340,938
8 MRNA
Moderna, Inc.
 1,521,849 $106,575,080

All Filings in RYTM

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $57,163,791 514,850
2026-03-31 $47,089,903 541,450
2025-12-31 $58,767,098 549,020
2025-09-30 $44,180,294 437,472
2025-06-30 $14,383,746 227,627
2025-03-31 $6,662,668 125,782
2024-12-31 $12,234,090 218,544
2024-09-30 $11,807,288 225,373
2024-06-30 $9,707,851 236,431
2024-03-31 $8,968,441 206,980
2023-12-31 $9,650,846 209,938
2023-09-30 $7,731,774 337,264
2023-06-30 $3,397,514 206,035
2023-03-31 $3,675,661 206,035
2022-12-31 $1,228,774 42,197
2022-09-30 $733,455 29,937
2022-06-30 $227,514 54,823
2022-03-31 $339,043 29,431
2021-12-31 $293,719 29,431
2021-09-30 $329,305 25,215
2021-06-30 $493,708 25,215
2021-03-31 $223,249 10,496
2020-12-31 $865,914 29,126
2020-09-30 $692,659 31,964
2020-06-30 $425,103 19,063